Phase I/II study of oral erlotinib for treatment of relapsed/refractory glioblastoma multiforme and anaplastic astrocytoma. (Q48389593)
Jump to navigation
Jump to search
scientific article published in January 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I/II study of oral erlotinib for treatment of relapsed/refractory glioblastoma multiforme and anaplastic astrocytoma. |
scientific article published in January 2012 |
Statements
Phase I/II study of oral erlotinib for treatment of relapsed/refractory glioblastoma multiforme and anaplastic astrocytoma (English)
Apostolos J Tsiouris
Kartik Kesavabhotla
Cody D Schlaff
Benjamin Shin
Lynn Mubita
Rachel Kaplan
Susan C Pannullo
Paul Christos
Ehud Lavi
Ronald Scheff
John A Boockvar